Sinopharm, China's biggest pharmaceuticals distributor, saw its shares jump nearly 16 per cent on its market debut in Hong Kong yesterday, as investors hoped that the country's healthcare reform could spur growth.
中國最大的醫藥分銷商國藥控股(Sinopharm)昨日在香港上市首日大漲近16%，投資者期望中國的醫療改革能刺激醫藥板塊的增長。
您已閱讀14%（277字），剩余86%（1687字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。